The utility of immunostaining for NUT, GAGE7 and NY-ESO-1 in the diagnosis of spermatocytic seminoma

NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms

(2013) Jessica A Hemminger et al.   MODERN PATHOLOGY

Solid Pattern Yolk Sac Tumor

(2012) Chia-Sui Kao et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

(2012) Seth M. Pollack et al.   CANCER

The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas

(2012) Jessica A Hemminger et al.   MODERN PATHOLOGY

Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma

(2011) Y.-T. Chen et al.   HUMAN REPRODUCTION

Spermatocytic seminoma associated with undifferentiated sarcoma: A rare case report

(2011) Priti Trivedi et al.   Indian Journal of Pathology and Microbiology

OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia

(2011) Jasmine Lim et al.   JOURNAL OF PATHOLOGY

SALL4 Is a Novel Diagnostic Marker for Testicular Germ Cell Tumors

(2009) Dengfeng Cao et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody

(2009) Herbert Haack et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY